1 enrolling by invitation. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Enrolling by invitation 1 |
Follow Suppuration: new trials by email Literature Review of Suppuration trials Research Report on Suppuration
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Moderate to Severe Hidradenitis Suppurativa Sonelokimab - Hidradenitis Suppurativa | Phase 3 | Enrolling by invitation | MoonLake Immunotherapeutics AG | 835 | 2025-06-27 | 2026-06-08 |
Hidradenitis (1) · Hidradenitis Suppurativa (1) · Skin Diseases (1) · Skin Diseases, Bacterial (1) · Sweat Gland Diseases (1)
Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Infections (1) · Inflammation (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Skin Diseases, Infectious (1) · Skin and Connective Tissue Diseases (1)
sonelokimab (1)
MoonLake Immunotherapeutics AG (1)
Belgium (1) · Bulgaria (1) · Canada (1) · Czechia (1) · France (1) · Germany (1) · Hungary (1) · Italy (1) · Netherlands (1) · Norway (1) · Poland (1) · Portugal (1) · Slovakia (1) · Spain (1) · United Kingdom (1)